Jane Street’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-23,208
| Closed | -$119K | – | 11653 |
|
|
2025
Q2 | $88.4K | Buy |
+23,208
| New | +$72K | ﹤0.01% | 9003 |
|
|
2025
Q1 | – | Sell |
-33,009
| Closed | -$117K | – | 10467 |
|
|
2024
Q4 | $117K | Buy |
33,009
+9,524
| +41% | +$36.5K | ﹤0.01% | 8703 |
|
|
2024
Q3 | $107K | Sell |
23,485
-20,206
| -46% | -$97.7K | ﹤0.01% | 8974 |
|
|
2024
Q2 | $190K | Buy |
43,691
+8,234
| +23% | +$36.2K | ﹤0.01% | 8430 |
|
|
2024
Q1 | $178K | Buy |
35,457
+11,575
| +48% | +$64.8K | ﹤0.01% | 8251 |
|
|
2023
Q4 | $150K | Buy |
+23,882
| New | +$137K | ﹤0.01% | 8396 |
|
|
2023
Q3 | – | Sell |
-36,204
| Closed | -$369K | – | 9291 |
|
|
2023
Q2 | $369K | Sell |
36,204
-114,928
| -76% | -$1.2M | ﹤0.01% | 6803 |
|
|
2023
Q1 | $1.37M | Buy |
151,132
+91,819
| +155% | +$673K | ﹤0.01% | 4451 |
|
|
2022
Q4 | $425K | Buy |
+59,313
| New | +$362K | ﹤0.01% | 6419 |
|
Jane Street's SCPH Position: Q3 2025 in Review
Jane Street sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 23,208 shares — an estimated $119K sold.
Jane Street first reported a position in SCPH in Q4 2022 and held it in 9 quarters. The position peaked at $1.37M in Q1 2023. 110 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.
- Jane Street reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Jane Street sold 23,208 scPharmaceuticals shares in Q3 2025, an estimated $119K.
- Jane Street first reported a position in scPharmaceuticals in Q4 2022 and held it in 9 quarters.
- Jane Street's scPharmaceuticals position peaked at $1.37M in Q1 2023.
- 110 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.
Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.